other_material
confidence high
sentiment positive
materiality 0.55
CERo Therapeutics raises $1.85M via Series D preferred stock; adds new institutional investors
CERO THERAPEUTICS HOLDINGS, INC.
- Closed additional closing of 2,315 shares of Series D convertible preferred stock for gross proceeds of ~$1,852,000.
- Entered into Amendment No. 1 to the Securities Purchase Agreement adding new institutional investors as buyers.
- New investors join through joinder agreements, becoming parties to the existing Securities Purchase Agreement.
- The Series D preferred stock is convertible into shares of CERO common stock; offering exempt under Rule 506/Section 4(a)(2).
item 1.01item 3.02item 9.01